Although overall survival (OS) did not reach statistical significance, a notable trend toward poorer OS was evident among patients exhibiting higher levels of ENO1 compared with those with lower levels ( Figure 1 E).
← all excerpts
ENO1 promotes acute myeloid leukemia progression through SCD1-mediated lipid metabolism reprogramming.
1
—
—